These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10721003)

  • 1. Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system.
    Liu JL; Yakar S; LeRoith D
    Proc Soc Exp Biol Med; 2000 Apr; 223(4):344-51. PubMed ID: 10721003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.
    Liu JL; Grinberg A; Westphal H; Sauer B; Accili D; Karas M; LeRoith D
    Mol Endocrinol; 1998 Sep; 12(9):1452-62. PubMed ID: 9731712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth.
    Liu JL; Yakar S; LeRoith D
    Endocrinology; 2000 Dec; 141(12):4436-41. PubMed ID: 11108252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative importance of endocrine versus autocrine/paracrine insulin-like growth factor-I in the regulation of body growth.
    Ohlsson C; Sjögren K; Jansson JO; Isaksson OG
    Pediatr Nephrol; 2000 Jul; 14(7):541-3. PubMed ID: 10912515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone.
    Liu JL; LeRoith D
    Endocrinology; 1999 Nov; 140(11):5178-84. PubMed ID: 10537147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone/insulin-like growth factor-I system: implications for organ growth and development.
    Yakar S; Liu JL; Le Roith D
    Pediatr Nephrol; 2000 Jul; 14(7):544-9. PubMed ID: 10912516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal growth and development in the absence of hepatic insulin-like growth factor I.
    Yakar S; Liu JL; Stannard B; Butler A; Accili D; Sauer B; LeRoith D
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7324-9. PubMed ID: 10377413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Endocrine; 2002 Dec; 19(3):249-56. PubMed ID: 12624424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatomedin hypothesis revisited in a transgenic model.
    Isaksson O; Ohlsson C; Sjögren K; Wallenius K; Jansson JO
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S49-52. PubMed ID: 11527088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of growth hormone and insulinlike growth factor-I on body growth and adult bone metabolism.
    Ohlsson C; Jansson JO; Isaksson O
    Curr Opin Rheumatol; 2000 Jul; 12(4):346-8. PubMed ID: 10910189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles.
    Butler AA; Le Roith D
    Annu Rev Physiol; 2001; 63():141-64. PubMed ID: 11181952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein calorie restriction affects nonhepatic IGF-I production and the lymphoid system: studies using the liver-specific IGF-I gene-deleted mouse model.
    Naranjo WM; Yakar S; Sanchez-Gomez M; Perez AU; Setser J; LERoith D
    Endocrinology; 2002 Jun; 143(6):2233-41. PubMed ID: 12021187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.
    Govoni KE; Wergedal JE; Florin L; Angel P; Baylink DJ; Mohan S
    Endocrinology; 2007 Dec; 148(12):5706-15. PubMed ID: 17717052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels.
    Temmerman L; Slonimsky E; Rosenthal N
    Growth Horm IGF Res; 2010 Jun; 20(3):255-63. PubMed ID: 20382057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of circulating IGF-I?
    Le Roith D; Scavo L; Butler A
    Trends Endocrinol Metab; 2001 Mar; 12(2):48-52. PubMed ID: 11167121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First advances in molecular endocrinology obtained using the Cre/LoxP system].
    Pankov IuA
    Mol Biol (Mosk); 2001; 35(3):372-5. PubMed ID: 11443915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth.
    Wang J; Zhou J; Cheng CM; Kopchick JJ; Bondy CA
    J Endocrinol; 2004 Feb; 180(2):247-55. PubMed ID: 14765976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology.
    Butler AA; LeRoith D
    Endocrinology; 2001 May; 142(5):1685-8. PubMed ID: 11316729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.
    Sjögren K; Liu JL; Blad K; Skrtic S; Vidal O; Wallenius V; LeRoith D; Törnell J; Isaksson OG; Jansson JO; Ohlsson C
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7088-92. PubMed ID: 10359843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.